Akanda Corp. Prices Public Offering
Ticker: AKAN · Form: 6-K · Filed: Oct 2, 2024 · CIK: 1888014
| Field | Detail |
|---|---|
| Company | Akanda Corp. (AKAN) |
| Form Type | 6-K |
| Filed Date | Oct 2, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: public-offering, financing, sec-filing
TL;DR
Akanda Corp. priced its public offering on Oct 2, 2024. Details in 6-K.
AI Summary
On October 2, 2024, Akanda Corp. announced the pricing of its underwritten public offering. The company, incorporated in the UK and operating in the medicinal chemicals and botanical products sector, filed this report on Form 6-K to include the press release detailing this offering.
Why It Matters
This filing indicates Akanda Corp. is raising capital through a public offering, which could impact its financial resources and future operations.
Risk Assessment
Risk Level: medium — Public offerings can be subject to market conditions and investor sentiment, and the success of the offering will impact the company's financial health.
Key Players & Entities
- Akanda Corp. (company) — Registrant
- October 2, 2024 (date) — Date of press release and pricing
- 2833 (industry_code) — Standard Industrial Classification for Medicinal Chemicals & Botanical Products
FAQ
What type of offering did Akanda Corp. announce?
Akanda Corp. announced the pricing of its underwritten public offering.
When was the press release announcing the offering pricing issued?
The press release was issued on October 2, 2024.
What form is this SEC filing?
This is a Form 6-K filing.
What is Akanda Corp.'s Standard Industrial Classification code?
Akanda Corp.'s SIC code is 2833, for Medicinal Chemicals & Botanical Products.
Does this filing include the annual report?
No, this filing is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 and indicates the company files annual reports under Form 20-F.
Filing Stats: 250 words · 1 min read · ~1 pages · Grade level 11 · Accepted 2024-10-02 08:30:07
Filing Documents
- ea0216436-6k_akanda.htm (6-K) — 10KB
- ea021643601ex99-1_akanda.htm (EX-99.1) — 7KB
- 0001213900-24-084330.txt ( ) — 18KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: October 2, 2024 AKANDA CORP. (Registrant) By: /s/ Katharyn Field Name: Katharyn Field Title: Interim Chief Executive Officer and Director 2